NutriTech: Application of New Technologies and Tools to Nutrition Research

Sponsor
Imperial College London (Other)
Overall Status
Completed
CT.gov ID
NCT01684917
Collaborator
(none)
36
1
3
45
0.8

Study Details

Study Description

Brief Summary

The overall objective of the research is to develop new methods for studying the link between diet, health and disease.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Metabolomic and Energy Intake Restriction
N/A

Detailed Description

The enquiry consists of two part. A metabolomic biomarker discovery study followed by a randomised controlled trial of moderate dietary induced weight loss.

A cohort of moderately overweight men and women will undergo a metabolomic study follow by randomised controlled trial of a healthy diet with a 20% energy restriction for a 12 week period. This intervention will improve the volunteer's body composition and reduce their risk of developing diabetes.

Extensive tests will be conducted before and after the dietary intervention using emerging technologies with current state-of-the-art methods. These tests will monitor the numerous physiological adaptations that have occurred on a gene, cell, organ and organismic level.

The study will, therefore, aim for a scientific breakthrough by developing a series of novel biological "markers" that can accurately determine an individual's health status.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Application of New Technologies and Tools to Nutrition Research
Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jan 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Life style advice

reduce energy intake by 20% less than estimated energy expenditure.

Behavioral: Metabolomic and Energy Intake Restriction
Metabolomic inquiry followed by a 12 week energy intake restriction. This study is part of a very large European study called EPIC. Only the results by Lee et al. 2016 have been presented here. The results of the study published by Cheung 2017 are from a different study. therefore the entries for the results are correct. For this particular study, participants were not randomly assigned to one of five different diets; red meat, fish, poultry, processed meat or a supplement and vegetarian option. In summary, both studies (lee and cheung) are considered as separate trials and results of the first phase where participants were assigned to one of five different diets, are reported separately. Unfortunately no different NCT number is available.
Other Names:
  • Energy restriction diet
  • Metabolomic
  • Active Comparator: UK background diet

    Diet where energy intake will be matched with estimated energy expenditure.

    Behavioral: Metabolomic and Energy Intake Restriction
    Metabolomic inquiry followed by a 12 week energy intake restriction. This study is part of a very large European study called EPIC. Only the results by Lee et al. 2016 have been presented here. The results of the study published by Cheung 2017 are from a different study. therefore the entries for the results are correct. For this particular study, participants were not randomly assigned to one of five different diets; red meat, fish, poultry, processed meat or a supplement and vegetarian option. In summary, both studies (lee and cheung) are considered as separate trials and results of the first phase where participants were assigned to one of five different diets, are reported separately. Unfortunately no different NCT number is available.
    Other Names:
  • Energy restriction diet
  • Metabolomic
  • Other: Metabolomic inquiry

    This inquiry took place prior to the randomized controlled trial and include 50 volunteers who will then be asked to volunteers of the weight loss study. Were randomly assigned to one of five different diets; red meat, fish, poultry, processed meat or a supplement and vegetarian option.

    Behavioral: Metabolomic and Energy Intake Restriction
    Metabolomic inquiry followed by a 12 week energy intake restriction. This study is part of a very large European study called EPIC. Only the results by Lee et al. 2016 have been presented here. The results of the study published by Cheung 2017 are from a different study. therefore the entries for the results are correct. For this particular study, participants were not randomly assigned to one of five different diets; red meat, fish, poultry, processed meat or a supplement and vegetarian option. In summary, both studies (lee and cheung) are considered as separate trials and results of the first phase where participants were assigned to one of five different diets, are reported separately. Unfortunately no different NCT number is available.
    Other Names:
  • Energy restriction diet
  • Metabolomic
  • Outcome Measures

    Primary Outcome Measures

    1. Insulin Sensitivity [Baseline, 12 weeks]

      Glucose Infusion rate assessed by the euglycemic hyperinsulinemic clamp. Insulin Sensitivity assessment was only performed in the "Exercise" and "Exercise, Control" groups. No data were collected for this Outcome from the remaining groups.

    2. Metabolomic Biomarker Discovery - Changes in Blood Plasma Cholesterol [Baseline, 12 weeks]

      Changes in blood plasma cholesterol in mg/dL- baseline to 12 weeks, after treatment. Statistical Analysis was performed only for the "Diet" Arm/Group.

    Secondary Outcome Measures

    1. Body Composition [Baseline, 12 weeks]

      Body Composition assessed by BMI

    2. Changes in Adipocyte Morphology [12 weeks]

      Percentage Change in total adipose tissue assessed by MRI

    3. Genome Integrity (DNA Methylation and Telomere Length) [12 weeks]

    4. Body Weight [Baseline, 12 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy overweight volunteers (body mass index (BMI) of 25-30 kg/m2)

    • Age between 50-65 years

    Exclusion Criteria:
    • Weight change of ≥ 3kg in the preceding 3 months

    • Current smokers

    • Substance abuse

    • Excess alcohol intake

    • Pregnancy

    • Diabetes

    • Cardiovascular disease

    • Cancer

    • Gastrointestinal disease e.g. inflammatory bowel disease or irritable bowel syndrome

    • Kidney disease

    • Liver disease

    • Pancreatitis

    • Have any metallic or magnetic implants such as pacemakers

    • Use of medications likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Imperial College London London United Kingdom W12 0NN

    Sponsors and Collaborators

    • Imperial College London

    Investigators

    • Principal Investigator: Gary S Frost, Imperial College London

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Imperial College London
    ClinicalTrials.gov Identifier:
    NCT01684917
    Other Study ID Numbers:
    • 12/L0/0139
    First Posted:
    Sep 13, 2012
    Last Update Posted:
    Jan 27, 2020
    Last Verified:
    Jan 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Imperial College London
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Exercise Diet Exercise, Control Diet, Control
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks. Energy intake was matched with estimated energy expenditure An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks Energy intake was matched with estimated energy expenditure
    Period Title: Overall Study
    STARTED 11 7 13 5
    COMPLETED 11 7 13 5
    NOT COMPLETED 0 0 0 0

    Baseline Characteristics

    Arm/Group Title Exercise Diet Exercise, Control Diet, Control Total
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks Total of all reporting groups
    Overall Participants 11 7 13 5 36
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    53
    (1.7)
    59
    (1.3)
    50
    (2.1)
    57
    (2.7)
    55
    (2)
    Sex: Female, Male (Count of Participants)
    Female
    0
    0%
    4
    57.1%
    0
    0%
    2
    40%
    6
    16.7%
    Male
    11
    100%
    3
    42.9%
    13
    100%
    3
    60%
    30
    83.3%
    Race and Ethnicity Not Collected (Count of Participants)
    Count of Participants [Participants]
    0
    0%
    Region of Enrollment (participants) [Number]
    United Kingdom
    11
    100%
    7
    100%
    13
    100%
    5
    100%
    36
    100%
    BMI (kg/m^2) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [kg/m^2]
    28.9
    (2.5)
    30.8
    (3.1)
    23.5
    (2)
    29.1
    (2)
    28
    (2.3)
    Fasting glucose (mmol/L) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [mmol/L]
    5.8
    (0.4)
    5.0
    (0.6)
    5.4
    (0.1)
    4.6
    (0.3)
    5.2
    (0.4)
    Total cholesterol (mg/dL) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [mg/dL]
    5.6
    (0.5)
    5.6
    (1.2)
    5.1
    (0.2)
    4.9
    (0.3)
    5.2
    (0.5)

    Outcome Measures

    1. Primary Outcome
    Title Insulin Sensitivity
    Description Glucose Infusion rate assessed by the euglycemic hyperinsulinemic clamp. Insulin Sensitivity assessment was only performed in the "Exercise" and "Exercise, Control" groups. No data were collected for this Outcome from the remaining groups.
    Time Frame Baseline, 12 weeks

    Outcome Measure Data

    Analysis Population Description
    No data available for diet and diet-control group
    Arm/Group Title Exercise Diet Exercise, Control Diet, Control
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks
    Measure Participants 11 0 13 0
    Baseline
    4.2
    (1.8)
    7.6
    (1.6)
    12 weeks
    5.4
    (1.8)
    10.4
    (2.6)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Exercise
    Comments Baseline vs 12 weeks
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value <0.05
    Comments calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance
    Method t-test, 2 sided
    Comments
    Statistical Analysis 2
    Statistical Analysis Overview Comparison Group Selection Exercise, Control
    Comments Baseline vs 12 weeks
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value <0.05
    Comments calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance.
    Method t-test, 2 sided
    Comments
    2. Primary Outcome
    Title Metabolomic Biomarker Discovery - Changes in Blood Plasma Cholesterol
    Description Changes in blood plasma cholesterol in mg/dL- baseline to 12 weeks, after treatment. Statistical Analysis was performed only for the "Diet" Arm/Group.
    Time Frame Baseline, 12 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Exercise Diet Exercise, Control Diet, Control
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks
    Measure Participants 11 7 13 5
    Baseline
    5.6
    (0.5)
    5.6
    (1.2)
    5.1
    (0.2)
    4.9
    (0.3)
    12 weeks
    5.8
    (0.7)
    4.9
    (1.3)
    4.9
    (0.1)
    5.1
    (0.3)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Diet
    Comments Baseline vs 12 weeks. Statistical Analysis was performed only for the "Diet" Arm/Group.
    Type of Statistical Test Superiority
    Comments Statistical Analysis was performed only for the "Diet" Arm/Group
    Statistical Test of Hypothesis p-Value <0.05
    Comments calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance
    Method t-test, 2 sided
    Comments
    3. Secondary Outcome
    Title Body Composition
    Description Body Composition assessed by BMI
    Time Frame Baseline, 12 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Exercise Diet Exercise, Control Diet, Control
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks
    Measure Participants 11 7 13 5
    Baseline
    28.9
    (2.5)
    30.8
    (3.1)
    23.5
    (2)
    29.1
    (2)
    12 weeks
    28.6
    (2.4)
    29.2
    (3)
    23.5
    (1.8)
    29.1
    (2)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Diet
    Comments Baseline vs 12 weeks. Statistical Analysis was performed only for the "Diet" Arm/Group.
    Type of Statistical Test Superiority
    Comments Statistical Analysis was performed only for the "Diet" Arm/Group
    Statistical Test of Hypothesis p-Value <0.05
    Comments calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance.
    Method t-test, 2 sided
    Comments
    4. Secondary Outcome
    Title Changes in Adipocyte Morphology
    Description Percentage Change in total adipose tissue assessed by MRI
    Time Frame 12 weeks

    Outcome Measure Data

    Analysis Population Description
    1 missing data in diet group
    Arm/Group Title Exercise Diet Exercise, Control Diet, Control
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks
    Measure Participants 7 6 13 5
    Mean (Standard Error) [percentage change]
    -10.9
    (5.1)
    -8.9
    (3.3)
    -8.5
    (2.7)
    3.7
    (1.4)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Exercise
    Comments Baseline vs 12 weeks
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value <0.05
    Comments The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance
    Method t-test, 2 sided
    Comments
    Statistical Analysis 2
    Statistical Analysis Overview Comparison Group Selection Diet
    Comments Baseline vs 12 weeks
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value <0.05
    Comments The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance
    Method t-test, 2 sided
    Comments
    Statistical Analysis 3
    Statistical Analysis Overview Comparison Group Selection Exercise, Control
    Comments Baseline vs 12 weeks
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value <0.05
    Comments The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance
    Method t-test, 2 sided
    Comments
    5. Secondary Outcome
    Title Genome Integrity (DNA Methylation and Telomere Length)
    Description
    Time Frame 12 weeks

    Outcome Measure Data

    Analysis Population Description
    Data not collected
    Arm/Group Title Exercise Diet Exercise, Control Diet, Control
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks
    Measure Participants 0 0 0 0
    6. Secondary Outcome
    Title Body Weight
    Description
    Time Frame Baseline, 12 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Exercise Diet Exercise, Control Diet, Control
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks
    Measure Participants 11 7 13 5
    Baseline
    92.9
    (9)
    91.9
    (17.8)
    78.5
    (2.3)
    84.7
    (4.8)
    12 weeks
    91.6
    (9.1)
    87.3
    (17.4)
    78.3
    (2.3)
    84.5
    (4.9)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Diet
    Comments Baseline vs 12 weeks. Statistical Analysis was performed only for the "Diet" Arm/Group.
    Type of Statistical Test Superiority
    Comments Statistical Analysis was performed only for the "Diet" Arm/Group
    Statistical Test of Hypothesis p-Value <0.05
    Comments calculated. The reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance
    Method t-test, 2 sided
    Comments

    Adverse Events

    Time Frame 12 weeks
    Adverse Event Reporting Description
    Arm/Group Title Exercise Diet Exercise, Control Diet, Control
    Arm/Group Description An overweight/dysglycemic group 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism with energy restriction, 20% reduced intake of energy from food for 12 weeks An overweight with no dysglycemia 4 h of intense exercise each week, including two whole-body strength-training sessions and two spinning bike interval sessions for 12 weeks overweight/ obese subjects with normal glucose metabolism for 12 weeks
    All Cause Mortality
    Exercise Diet Exercise, Control Diet, Control
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/11 (0%) 0/7 (0%) 0/13 (0%) 0/5 (0%)
    Serious Adverse Events
    Exercise Diet Exercise, Control Diet, Control
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/11 (0%) 0/7 (0%) 0/13 (0%) 0/5 (0%)
    Other (Not Including Serious) Adverse Events
    Exercise Diet Exercise, Control Diet, Control
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/11 (0%) 0/7 (0%) 0/13 (0%) 0/5 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Professor Gary Frost
    Organization Imperial College London
    Phone +44 (0)20 7594 0959
    Email g.frost@imperial.ac.uk
    Responsible Party:
    Imperial College London
    ClinicalTrials.gov Identifier:
    NCT01684917
    Other Study ID Numbers:
    • 12/L0/0139
    First Posted:
    Sep 13, 2012
    Last Update Posted:
    Jan 27, 2020
    Last Verified:
    Jan 1, 2020